CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
Recruiting · NCT06445803 · Registry updated 2024-06-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2024-06-06 | NCT06445803 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 3 |
| Rong Tao | 5 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |
| The First Affiliated Hospital of Nanchang University; | Nanchang | China | 1 |